We are live on
!
Find out more
Verrica Pharmaceuticals
VRCA
VRCA
42 hedge funds and large institutions have $137M invested in Verrica Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
31% more capital invested
Capital invested by funds: $105M → $137M (+$32M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
2% more funds holding
Funds holding: 41 → 42 (+1)
0.09% more ownership
Funds ownership: 3.51% → 3.6% (+0.09%)
Holders
42
Holders Change
+1
Holders Change %
+2.44%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
17
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.43M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$964K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$689K |
| 4 |
BlackRock
New York
|
+$678K |
| 5 |
State Street
Boston,
Massachusetts
|
+$302K |
